PROM1 and hepatocellular carcinoma: Consistently, Spink1 was also found to be enhanced  in HCC tumors enriched for a CD133+ liver tumor-initiating/propagating cell subset following either 5-FU or cisplatin treatment (Supplementary Fig. S1b).